Brian M. Stuglik, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 13,000 shares at $2.69 ($35K) on 2022-06-16, disclosed to the SEC on 2022-06-21.
Scheduled sale ($35k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VSTM | SELL | 2025-09-18 | $6K | — | Filing → |
| VSTM | SELL | 2025-06-20 | $3K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $27K | — | Filing → |